Log in

DEX DEXTECH MEDICAL AB NGM · Sweden

DEXTECH MEDICAL AB (DEX) news

DEXTECH MEDICAL AB is a public biotech or pharmaceutical company listed on NGM under the ticker DEX, recorded under Sweden. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest DEXTECH MEDICAL AB news

We have not published a story on DEXTECH MEDICAL AB yet. When there is news, it will appear here.

Questions about DEXTECH MEDICAL AB

What is the ticker symbol of DEXTECH MEDICAL AB?

DEXTECH MEDICAL AB trades under the ticker DEX on NGM.

Where is DEXTECH MEDICAL AB listed?

DEXTECH MEDICAL AB is listed on NGM.

Which country or territory is DEXTECH MEDICAL AB listed under?

Our directory records DEXTECH MEDICAL AB under Sweden.

What does DEXTECH MEDICAL AB do?

Our directory classifies DEXTECH MEDICAL AB as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline.

What is the ISIN of DEXTECH MEDICAL AB?

The ISIN recorded for DEXTECH MEDICAL AB is SE0005881489.

Does aibio.space cover DEXTECH MEDICAL AB?

aibio.space lists DEXTECH MEDICAL AB among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to DEXTECH MEDICAL AB?

Companies in our directory listed in the same country and business area as DEXTECH MEDICAL AB: Larkberget AB, Sprint Bioscience AB, APTAHEM AB, BioArctic AB, Annexin Pharmaceuticals AB, Diamyd Medical AB.

Investor discussion: DEXTECH MEDICAL AB

Members talk about DEXTECH MEDICAL AB (DEX). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open NGM:DEX on TradingView.

Listing details

DEXTECH MEDICAL AB is a public biotech or pharmaceutical company listed on NGM under the ticker DEX, recorded under Sweden. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
DEXTECH MEDICAL AB
Ticker
DEX
Listing
NGM
Country or territory
Sweden
Business scope
Pharmaceuticals: Major
ISIN
SE0005881489
Last quote in directory
2026-10-21
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

aibio.space

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.